ICH Consults On Guideline To Improve Bioanalytical Data Consistency
Executive Summary
The finalization of a new international guideline that proposes a harmonized approach on bioanalytical method validation is expected to reduce the need for additional validation experiments and support streamlined global drug development.
You may also be interested in...
EMA Considers Product Development Stage For Complying With ICH Guide On Bioanalytical Method Validation
The European Medicines Agency has drafted a plan to address specific issues that drug companies may face when it comes to complying with the International Council for Harmonisation’s M10 guideline.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.